SCHEMBL16237277

SCHEMBL16237277

CC(=O)NC(CN)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.45
BLM P54132 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
NFKB1 P19838 1/20 0.45
PTGS2 P35354 1/20 0.45
THPO P40225 1/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 1/20 0.43
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
SIRT6 Q8N6T7 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
SIRT5 Q9NXA8 2/20 0.36
ALB P02768 1/20 0.35
CRBN Q96SW2 1/20 0.35
GNPAT O15228 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22592147 0.82 KDM4E (0.42) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL28243836 0.81 MAPT (0.61) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL468816 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL1576871 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL8134268 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL27410307 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL468815 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL13953561 0.81 KDM4E (0.45) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL11134229 0.81 MAPT (0.61) ALOX15BLMKDM4EMAPTTHRB
SCHEMBL20951073 0.80 ALDH1A1 (0.53) ALDH1A1SIRT5GNPATCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190142941-A1 BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same ABBVIE INC (US) 2019-05-16 US disclosed
US-20150328283-A1 NOVEL ANTIMICROBIAL AGENTS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2015-11-19 US disclosed
WO-2014184584-A1 DELIVERY PEPTIDES KING'S COLLEGE LONDON (GB) 2014-11-20 WO disclosed
US-20110136726-A1 NOVEL ANTIMICROBIAL AGENTS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136726-A1 NOVEL ANTIMICROBIAL AGENTS NOTUM, DAO, SLC11A2 ALOX15 584/4885BLM 3997/4885KDM4E 4611/4885
US-20150328283-A1 NOVEL ANTIMICROBIAL AGENTS ALOX15B, ALOX15, ALOX12 ALOX15 2/4885BLM 4019/4885KDM4E 4649/4885
US-20190142941-A1 BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same BCL2, BAX, BCL9 ALOX15 3591/4885BLM 2239/4885KDM4E 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.